anti hvcn1 antibody Search Results


  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94
    Alomone Labs anti hvcn1 antibody
    Anti Hvcn1 Antibody, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti hvcn1 antibody/product/Alomone Labs
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti hvcn1 antibody - by Bioz Stars, 2022-12
    94/100 stars
      Buy from Supplier

    93
    OriGene hvcn1 rabbit polyclonal antibody
    Upregulation of <t>HVCN1</t> in microglia/macrophage in neurodegenerative diseases of the central nervous system. (A,B) Representative Western blot images (A) and quantification of densities (B) of HVCN1 in the whole brain of SOD1 G 93 A mice and their littermates B6SJL mice ( n = 5). (C–F) Representative immunofluorescence images (C,E) and quantification of the proportion (D,F) : HVCN1 (red) is expressed in Iba1 + microglia/macrophages (green) in the brain (C,D) and the spinal cord (E,F) of SOD1 G 93 A mice and their littermates B6SJL mice ( n = 3). (G,H) Representative immunofluorescence images (G) and quantification of the proportion (H): HVCN1 (red) is expressed in Iba1 + microglia/macrophages (green) in the brain of wild type (WT) and R6/2 mouse ( n = 3). (I) HVCN1 mRNA level in the peripheral blood of patients with Huntington’s Disease ( n = 14) in comparison with the healthy control subjects ( n = 12) ( Borovecki et al., 2005 ). Scale bars (C,E,G) = 20 μm; the side length of the dashed-line square = 5 μm. Data are presented as mean ± SEM. Statistical tests: unpaired two-tailed t -test (B,D,F,H,I) ; * p
    Hvcn1 Rabbit Polyclonal Antibody, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hvcn1 rabbit polyclonal antibody/product/OriGene
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    hvcn1 rabbit polyclonal antibody - by Bioz Stars, 2022-12
    93/100 stars
      Buy from Supplier

    93
    Alomone Labs rabbit polyclonal anti h1 receptor
    Upregulation of <t>HVCN1</t> in microglia/macrophage in neurodegenerative diseases of the central nervous system. (A,B) Representative Western blot images (A) and quantification of densities (B) of HVCN1 in the whole brain of SOD1 G 93 A mice and their littermates B6SJL mice ( n = 5). (C–F) Representative immunofluorescence images (C,E) and quantification of the proportion (D,F) : HVCN1 (red) is expressed in Iba1 + microglia/macrophages (green) in the brain (C,D) and the spinal cord (E,F) of SOD1 G 93 A mice and their littermates B6SJL mice ( n = 3). (G,H) Representative immunofluorescence images (G) and quantification of the proportion (H): HVCN1 (red) is expressed in Iba1 + microglia/macrophages (green) in the brain of wild type (WT) and R6/2 mouse ( n = 3). (I) HVCN1 mRNA level in the peripheral blood of patients with Huntington’s Disease ( n = 14) in comparison with the healthy control subjects ( n = 12) ( Borovecki et al., 2005 ). Scale bars (C,E,G) = 20 μm; the side length of the dashed-line square = 5 μm. Data are presented as mean ± SEM. Statistical tests: unpaired two-tailed t -test (B,D,F,H,I) ; * p
    Rabbit Polyclonal Anti H1 Receptor, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal anti h1 receptor/product/Alomone Labs
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    rabbit polyclonal anti h1 receptor - by Bioz Stars, 2022-12
    93/100 stars
      Buy from Supplier

    96
    Millipore anti hvcn1 antibody produced in rabbit
    AAT augmentation therapy increases <t>HVCN1</t> neutrophil plasma membrane expression. HVCN1 membrane expression of AATD neutrophils before (day 0) and 2 days after augmentation therapy (day 2) assessed by flow cytometry. HVCN1 expressing neutrophils were significantly higher on day 2 after therapy ( p = 0.014, n = 3, Student’s paired t test).
    Anti Hvcn1 Antibody Produced In Rabbit, supplied by Millipore, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti hvcn1 antibody produced in rabbit/product/Millipore
    Average 96 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti hvcn1 antibody produced in rabbit - by Bioz Stars, 2022-12
    96/100 stars
      Buy from Supplier

    Image Search Results


    Upregulation of HVCN1 in microglia/macrophage in neurodegenerative diseases of the central nervous system. (A,B) Representative Western blot images (A) and quantification of densities (B) of HVCN1 in the whole brain of SOD1 G 93 A mice and their littermates B6SJL mice ( n = 5). (C–F) Representative immunofluorescence images (C,E) and quantification of the proportion (D,F) : HVCN1 (red) is expressed in Iba1 + microglia/macrophages (green) in the brain (C,D) and the spinal cord (E,F) of SOD1 G 93 A mice and their littermates B6SJL mice ( n = 3). (G,H) Representative immunofluorescence images (G) and quantification of the proportion (H): HVCN1 (red) is expressed in Iba1 + microglia/macrophages (green) in the brain of wild type (WT) and R6/2 mouse ( n = 3). (I) HVCN1 mRNA level in the peripheral blood of patients with Huntington’s Disease ( n = 14) in comparison with the healthy control subjects ( n = 12) ( Borovecki et al., 2005 ). Scale bars (C,E,G) = 20 μm; the side length of the dashed-line square = 5 μm. Data are presented as mean ± SEM. Statistical tests: unpaired two-tailed t -test (B,D,F,H,I) ; * p

    Journal: Frontiers in Cellular Neuroscience

    Article Title: Neutralization of Hv1/HVCN1 With Antibody Enhances Microglia/Macrophages Myelin Clearance by Promoting Their Migration in the Brain

    doi: 10.3389/fncel.2021.768059

    Figure Lengend Snippet: Upregulation of HVCN1 in microglia/macrophage in neurodegenerative diseases of the central nervous system. (A,B) Representative Western blot images (A) and quantification of densities (B) of HVCN1 in the whole brain of SOD1 G 93 A mice and their littermates B6SJL mice ( n = 5). (C–F) Representative immunofluorescence images (C,E) and quantification of the proportion (D,F) : HVCN1 (red) is expressed in Iba1 + microglia/macrophages (green) in the brain (C,D) and the spinal cord (E,F) of SOD1 G 93 A mice and their littermates B6SJL mice ( n = 3). (G,H) Representative immunofluorescence images (G) and quantification of the proportion (H): HVCN1 (red) is expressed in Iba1 + microglia/macrophages (green) in the brain of wild type (WT) and R6/2 mouse ( n = 3). (I) HVCN1 mRNA level in the peripheral blood of patients with Huntington’s Disease ( n = 14) in comparison with the healthy control subjects ( n = 12) ( Borovecki et al., 2005 ). Scale bars (C,E,G) = 20 μm; the side length of the dashed-line square = 5 μm. Data are presented as mean ± SEM. Statistical tests: unpaired two-tailed t -test (B,D,F,H,I) ; * p

    Article Snippet: Primary antibodies used were as follows: Rabbit anti-HVCN1 (Origene, TA328862, 1:1000), horseradish peroxidase (HRP) conjugated mouse anti-HA (Millipore, H6533, 1:10, 000), mouse anti-β-tubulin (HUABIO, Hangzhou, China, M1305-2, 1:2000), mouse anti-β-actin (Sigma, A5441, 1:10,000).

    Techniques: Western Blot, Mouse Assay, Immunofluorescence, Two Tailed Test

    Knockdown of HVCN1 does not affect myelin phagocytosis and lysosome acidification in vitro . (A) Representative immunofluorescence images show that Hvcn1 knockdown by Cy3 labeled siRNA (red) does not affect myelin phagocytosis (green) in CD11b + BMDM (blue). Scale bar = 100 μm. Arrows indicate two example BMDM cells that phagocytized myelin. Flow cytometry chart (B) and the quantification graphs (C,D) show that Hvcn1 knockdown does not affect both the proportion of cells phagocytizing myelin (C) and the relative phagocytic index (D) in CFSE-labeled myelin phagocytosis assay in BMDM cells ( n = 3). Flow cytometry chart (E) and the quantification graphs (F,G) show that Hvcn1 knockout does not affect both the proportion of cells phagocytizing myelin (F) and the relative phagocytic index (G) in CFSE-labeled myelin phagocytosis assay in primary cultured microglia cells ( n = 5). Flow cytometry chart (H) and the quantification graphs (I,J) show that Hvcn1 knockdown does not affect the proportion of cells phagocytizing myelin (I) and the relative phagocytic index (J) in pHrodo-myelin phagocytosis assay in BMDM cells ( n = 7). Data are presented as mean ± SEM. Statistical tests: unpaired two-tailed t -test (C,D,F,G,I,J) .

    Journal: Frontiers in Cellular Neuroscience

    Article Title: Neutralization of Hv1/HVCN1 With Antibody Enhances Microglia/Macrophages Myelin Clearance by Promoting Their Migration in the Brain

    doi: 10.3389/fncel.2021.768059

    Figure Lengend Snippet: Knockdown of HVCN1 does not affect myelin phagocytosis and lysosome acidification in vitro . (A) Representative immunofluorescence images show that Hvcn1 knockdown by Cy3 labeled siRNA (red) does not affect myelin phagocytosis (green) in CD11b + BMDM (blue). Scale bar = 100 μm. Arrows indicate two example BMDM cells that phagocytized myelin. Flow cytometry chart (B) and the quantification graphs (C,D) show that Hvcn1 knockdown does not affect both the proportion of cells phagocytizing myelin (C) and the relative phagocytic index (D) in CFSE-labeled myelin phagocytosis assay in BMDM cells ( n = 3). Flow cytometry chart (E) and the quantification graphs (F,G) show that Hvcn1 knockout does not affect both the proportion of cells phagocytizing myelin (F) and the relative phagocytic index (G) in CFSE-labeled myelin phagocytosis assay in primary cultured microglia cells ( n = 5). Flow cytometry chart (H) and the quantification graphs (I,J) show that Hvcn1 knockdown does not affect the proportion of cells phagocytizing myelin (I) and the relative phagocytic index (J) in pHrodo-myelin phagocytosis assay in BMDM cells ( n = 7). Data are presented as mean ± SEM. Statistical tests: unpaired two-tailed t -test (C,D,F,G,I,J) .

    Article Snippet: Primary antibodies used were as follows: Rabbit anti-HVCN1 (Origene, TA328862, 1:1000), horseradish peroxidase (HRP) conjugated mouse anti-HA (Millipore, H6533, 1:10, 000), mouse anti-β-tubulin (HUABIO, Hangzhou, China, M1305-2, 1:2000), mouse anti-β-actin (Sigma, A5441, 1:10,000).

    Techniques: In Vitro, Immunofluorescence, Labeling, Flow Cytometry, Phagocytosis Assay, Knock-Out, Cell Culture, Two Tailed Test

    Upregulation of HVCN1 in microglia/macrophage in multiple injuries. Representative immunofluorescence images (A) and quantification of the proportion (B) : HVCN1 (red) in Iba1 + (green) microglia/macrophages in focal demyelination lesion in corpus callosum of the mouse brain at 5 days after focal injection of lysolecithin (LPC). ( n = 4). Two HVCN1 + Iba1 + microglia are indicated as examples. (C) Immunofluorescence images show that HVCN1 (red) is expressed in both iNOS + (green, up) type and Arg1 + (green, down) type polarized IB4 + microglia/macrophages (gray). (D) The proportion of iNOS + and Arg1 + type microglia/macrophages in HVCN1 + cells ( n = 4/group). (E) The proportion of HVCN1 + cells in iNOS + and Arg1 + type microglia/macrophages ( n = 4/group). (F,G) Representative immunofluorescence images (E) and quantification of the proportion (F) : HVCN1 (red) in Iba1 + (green) microglia/macrophage in corpus callosum of mouse brain at 12 h after intraperitoneal (i.p.) injection of lipopolysaccharide (LPS). ( n = 3/group). Two HVCN1 + Iba1 + microglia are indicated as examples. Scale bars (A,C,E) = 20 μm; the side length of the dashed-line square = 5 μm. Data are presented as mean ± SEM. Statistical tests: unpaired two-tailed t -test (B,D,F) ; ** p

    Journal: Frontiers in Cellular Neuroscience

    Article Title: Neutralization of Hv1/HVCN1 With Antibody Enhances Microglia/Macrophages Myelin Clearance by Promoting Their Migration in the Brain

    doi: 10.3389/fncel.2021.768059

    Figure Lengend Snippet: Upregulation of HVCN1 in microglia/macrophage in multiple injuries. Representative immunofluorescence images (A) and quantification of the proportion (B) : HVCN1 (red) in Iba1 + (green) microglia/macrophages in focal demyelination lesion in corpus callosum of the mouse brain at 5 days after focal injection of lysolecithin (LPC). ( n = 4). Two HVCN1 + Iba1 + microglia are indicated as examples. (C) Immunofluorescence images show that HVCN1 (red) is expressed in both iNOS + (green, up) type and Arg1 + (green, down) type polarized IB4 + microglia/macrophages (gray). (D) The proportion of iNOS + and Arg1 + type microglia/macrophages in HVCN1 + cells ( n = 4/group). (E) The proportion of HVCN1 + cells in iNOS + and Arg1 + type microglia/macrophages ( n = 4/group). (F,G) Representative immunofluorescence images (E) and quantification of the proportion (F) : HVCN1 (red) in Iba1 + (green) microglia/macrophage in corpus callosum of mouse brain at 12 h after intraperitoneal (i.p.) injection of lipopolysaccharide (LPS). ( n = 3/group). Two HVCN1 + Iba1 + microglia are indicated as examples. Scale bars (A,C,E) = 20 μm; the side length of the dashed-line square = 5 μm. Data are presented as mean ± SEM. Statistical tests: unpaired two-tailed t -test (B,D,F) ; ** p

    Article Snippet: Primary antibodies used were as follows: Rabbit anti-HVCN1 (Origene, TA328862, 1:1000), horseradish peroxidase (HRP) conjugated mouse anti-HA (Millipore, H6533, 1:10, 000), mouse anti-β-tubulin (HUABIO, Hangzhou, China, M1305-2, 1:2000), mouse anti-β-actin (Sigma, A5441, 1:10,000).

    Techniques: Immunofluorescence, Injection, Two Tailed Test

    Neutralization of HVCN1 with antibody promotes cell migration in vivo . (A) Schematic in vivo experiment design: CFSE-labeled myelin was co-injected with IgG on one side or with an HVCN1 antibody on the other side of the S1 cerebral cortex of the mouse. (B) Representative images show that neutralization with HVCN1 antibody increases CD68 + cell (red) density in both the core area (C) and the peripheral area (P) of the myelin (green) injection site. (C) Quantification of CD68 + microglia/macrophages density in the core area (left column) and the peripheral area (right column) of the myelin injection site ( n = 9). Scale bar (B) = 100 μm. Data are presented as mean ± SEM. Statistical tests: paired two-tailed t -test (C) ; ** p

    Journal: Frontiers in Cellular Neuroscience

    Article Title: Neutralization of Hv1/HVCN1 With Antibody Enhances Microglia/Macrophages Myelin Clearance by Promoting Their Migration in the Brain

    doi: 10.3389/fncel.2021.768059

    Figure Lengend Snippet: Neutralization of HVCN1 with antibody promotes cell migration in vivo . (A) Schematic in vivo experiment design: CFSE-labeled myelin was co-injected with IgG on one side or with an HVCN1 antibody on the other side of the S1 cerebral cortex of the mouse. (B) Representative images show that neutralization with HVCN1 antibody increases CD68 + cell (red) density in both the core area (C) and the peripheral area (P) of the myelin (green) injection site. (C) Quantification of CD68 + microglia/macrophages density in the core area (left column) and the peripheral area (right column) of the myelin injection site ( n = 9). Scale bar (B) = 100 μm. Data are presented as mean ± SEM. Statistical tests: paired two-tailed t -test (C) ; ** p

    Article Snippet: Primary antibodies used were as follows: Rabbit anti-HVCN1 (Origene, TA328862, 1:1000), horseradish peroxidase (HRP) conjugated mouse anti-HA (Millipore, H6533, 1:10, 000), mouse anti-β-tubulin (HUABIO, Hangzhou, China, M1305-2, 1:2000), mouse anti-β-actin (Sigma, A5441, 1:10,000).

    Techniques: Neutralization, Migration, In Vivo, Labeling, Injection, Two Tailed Test

    HVCN1 genetic deletion in vitro promotes cell migration. (A) HVCN1 knockout strategy by CRISPR/Cas9 in Hela cells. Black boxes, exons; line, introns; Arrows, primers for PCR detection; Underlined, sgRNA targeted sequences; Bold, protospacer adjacent motif (PAM). (B) Genomic PCR products of WT and HVCN1 –/– Hela cells. The position of primers is shown in (A) . (C) Western blot images of HVCN1 in WT and HVCN1 –/– Hela cells. (D) Representative images of transwell assay. Scale bars = 100 μm. (E) Quantification of transwell assay ( n = 5). (F) A heatmap of migration related gene expression changes between WT and HVCN1 –/– 293T cells by RNA-seq. Data are presented as mean ± SEM. Statistical tests: unpaired two-tailed t -test (E) ; ** p

    Journal: Frontiers in Cellular Neuroscience

    Article Title: Neutralization of Hv1/HVCN1 With Antibody Enhances Microglia/Macrophages Myelin Clearance by Promoting Their Migration in the Brain

    doi: 10.3389/fncel.2021.768059

    Figure Lengend Snippet: HVCN1 genetic deletion in vitro promotes cell migration. (A) HVCN1 knockout strategy by CRISPR/Cas9 in Hela cells. Black boxes, exons; line, introns; Arrows, primers for PCR detection; Underlined, sgRNA targeted sequences; Bold, protospacer adjacent motif (PAM). (B) Genomic PCR products of WT and HVCN1 –/– Hela cells. The position of primers is shown in (A) . (C) Western blot images of HVCN1 in WT and HVCN1 –/– Hela cells. (D) Representative images of transwell assay. Scale bars = 100 μm. (E) Quantification of transwell assay ( n = 5). (F) A heatmap of migration related gene expression changes between WT and HVCN1 –/– 293T cells by RNA-seq. Data are presented as mean ± SEM. Statistical tests: unpaired two-tailed t -test (E) ; ** p

    Article Snippet: Primary antibodies used were as follows: Rabbit anti-HVCN1 (Origene, TA328862, 1:1000), horseradish peroxidase (HRP) conjugated mouse anti-HA (Millipore, H6533, 1:10, 000), mouse anti-β-tubulin (HUABIO, Hangzhou, China, M1305-2, 1:2000), mouse anti-β-actin (Sigma, A5441, 1:10,000).

    Techniques: In Vitro, Migration, Knock-Out, CRISPR, Polymerase Chain Reaction, Western Blot, Transwell Assay, Expressing, RNA Sequencing Assay, Two Tailed Test

    Both genetic deletion and overexpression of HVCN1 do not affect phagocytosis of myelin in 293T cells. (A) HVCN1 gene knockout strategy by CRISPR/Cas9 in 293T cells. Black boxes, exons; line, introns; Arrows, primers for PCR detection; Underlined, sgRNA targeted sequences; Bold, PAM. (B) Genomic PCR products of WT and HVCN1 –/– 293T cells. The position of primers is shown in (A) . (C) Western blot images of HVCN1 in WT and HVCN1 –/– 293T cells. (D–F) Flow cytometry chart (D) and the quantification graphs (E,F) : HVCN1 knockout does not affect both the proportion of cells phagocytizing myelin (E) and the relative phagocytic index (F) in CFSE-labeled-myelin phagocytosis assay in 293T cells ( n = 3). (G–I) Flow cytometry chart (G) and the quantification graphs (H,I) show that overexpression of HV CN1 does not affect both the proportion of cells phagocytizing myelin (H) and the relative phagocytic index (I) in CFSE-labeled-myelin phagocytosis assay in 293T cells ( n = 3). Data are presented as mean ± SEM. Statistical tests: two-way ANOVA with Sidak’s multiple comparison posttest (E,F) or unpaired two-tailed t -test (H,I) .

    Journal: Frontiers in Cellular Neuroscience

    Article Title: Neutralization of Hv1/HVCN1 With Antibody Enhances Microglia/Macrophages Myelin Clearance by Promoting Their Migration in the Brain

    doi: 10.3389/fncel.2021.768059

    Figure Lengend Snippet: Both genetic deletion and overexpression of HVCN1 do not affect phagocytosis of myelin in 293T cells. (A) HVCN1 gene knockout strategy by CRISPR/Cas9 in 293T cells. Black boxes, exons; line, introns; Arrows, primers for PCR detection; Underlined, sgRNA targeted sequences; Bold, PAM. (B) Genomic PCR products of WT and HVCN1 –/– 293T cells. The position of primers is shown in (A) . (C) Western blot images of HVCN1 in WT and HVCN1 –/– 293T cells. (D–F) Flow cytometry chart (D) and the quantification graphs (E,F) : HVCN1 knockout does not affect both the proportion of cells phagocytizing myelin (E) and the relative phagocytic index (F) in CFSE-labeled-myelin phagocytosis assay in 293T cells ( n = 3). (G–I) Flow cytometry chart (G) and the quantification graphs (H,I) show that overexpression of HV CN1 does not affect both the proportion of cells phagocytizing myelin (H) and the relative phagocytic index (I) in CFSE-labeled-myelin phagocytosis assay in 293T cells ( n = 3). Data are presented as mean ± SEM. Statistical tests: two-way ANOVA with Sidak’s multiple comparison posttest (E,F) or unpaired two-tailed t -test (H,I) .

    Article Snippet: Primary antibodies used were as follows: Rabbit anti-HVCN1 (Origene, TA328862, 1:1000), horseradish peroxidase (HRP) conjugated mouse anti-HA (Millipore, H6533, 1:10, 000), mouse anti-β-tubulin (HUABIO, Hangzhou, China, M1305-2, 1:2000), mouse anti-β-actin (Sigma, A5441, 1:10,000).

    Techniques: Over Expression, Gene Knockout, CRISPR, Polymerase Chain Reaction, Western Blot, Flow Cytometry, Knock-Out, Labeling, Phagocytosis Assay, Two Tailed Test

    Expression of HVCN1 in microglia in vitro and in the normal adult cerebral cortex of mouse, marmoset, and human. (A) Hvcn1 mRNA is highly expressed in primary cultured mouse bone marrow derived macrophages (BMDM) and rat microglia, while exhibits much lower level in oligodendrocyte progenitor cells (OPCs) and astrocyte of the rat brain ( n = 3). (B) Specificity validation of the HVCN1 antibody in vitro by Western blot and Hvcn1 is overexpressed (OE) by transfecting with pLenti-CMV-HVCN1-HA-p2A-GFP plasmid whereas knocked down with siHVCN1 in COS-7 cells. (C) Representative images of Western blot of primary cultured cells: HVCN1 protein is expressed highly in rat microglia and mouse BMDM while exhibits low levels in rat OPCs, oligodendrocyte (OL), and astrocyte. (D,E) Specificity validation of HVCN1 antibody in vivo by immunofluorescence: targeted deleting Hvcn1 in CamKIIα + neurons of Hvcn1 fl/fl mice by focal injection of AAV9-CamKIIα-Cre-p2A-GFP virus into the cerebral cortex. In GFP + (green, CamKIIα + ) neurons in the cortex, immunofluorescence of HVCN1 (red) exhibits abundant signal in control (D) while eliminates labeling after Hvcn1 is targeted deleted (E) . As examples, arrows indicate GFP + (CamKIIα + ) neurons, while arrowheads indicate CamKIIα negative cells. (F,G) Representative immunofluorescence images: HVCN1 (red) is expressed in Iba1 + microglia (green) in the cerebral cortex of mouse (F) and marmoset (G) . (H) Immunofluorescence images: HVCN1 (red) is expressed in a few SOX10 + oligodendrocytes (green, upper) but not in GFAP + astrocyte (green, lower) in the cerebral cortex of the mouse. (I) Schematic drawing shows the site of human brain samples. (J) Representative Western blot images of HVCN1 in the postmortem human brain. (K) HVCN1 mRNA level in the cortex of the postmortem human brain ( n = 4) and the microglia isolated from the human brain ( n = 7) of patients with epilepsy ( Gosselin et al., 2017 ). Scale bars (D–H) = 20 μm; the side length of the dashed-line square = 5 μm. Data are presented as mean ± SEM. Statistical tests: unpaired two-tailed t -test (K) ; * p

    Journal: Frontiers in Cellular Neuroscience

    Article Title: Neutralization of Hv1/HVCN1 With Antibody Enhances Microglia/Macrophages Myelin Clearance by Promoting Their Migration in the Brain

    doi: 10.3389/fncel.2021.768059

    Figure Lengend Snippet: Expression of HVCN1 in microglia in vitro and in the normal adult cerebral cortex of mouse, marmoset, and human. (A) Hvcn1 mRNA is highly expressed in primary cultured mouse bone marrow derived macrophages (BMDM) and rat microglia, while exhibits much lower level in oligodendrocyte progenitor cells (OPCs) and astrocyte of the rat brain ( n = 3). (B) Specificity validation of the HVCN1 antibody in vitro by Western blot and Hvcn1 is overexpressed (OE) by transfecting with pLenti-CMV-HVCN1-HA-p2A-GFP plasmid whereas knocked down with siHVCN1 in COS-7 cells. (C) Representative images of Western blot of primary cultured cells: HVCN1 protein is expressed highly in rat microglia and mouse BMDM while exhibits low levels in rat OPCs, oligodendrocyte (OL), and astrocyte. (D,E) Specificity validation of HVCN1 antibody in vivo by immunofluorescence: targeted deleting Hvcn1 in CamKIIα + neurons of Hvcn1 fl/fl mice by focal injection of AAV9-CamKIIα-Cre-p2A-GFP virus into the cerebral cortex. In GFP + (green, CamKIIα + ) neurons in the cortex, immunofluorescence of HVCN1 (red) exhibits abundant signal in control (D) while eliminates labeling after Hvcn1 is targeted deleted (E) . As examples, arrows indicate GFP + (CamKIIα + ) neurons, while arrowheads indicate CamKIIα negative cells. (F,G) Representative immunofluorescence images: HVCN1 (red) is expressed in Iba1 + microglia (green) in the cerebral cortex of mouse (F) and marmoset (G) . (H) Immunofluorescence images: HVCN1 (red) is expressed in a few SOX10 + oligodendrocytes (green, upper) but not in GFAP + astrocyte (green, lower) in the cerebral cortex of the mouse. (I) Schematic drawing shows the site of human brain samples. (J) Representative Western blot images of HVCN1 in the postmortem human brain. (K) HVCN1 mRNA level in the cortex of the postmortem human brain ( n = 4) and the microglia isolated from the human brain ( n = 7) of patients with epilepsy ( Gosselin et al., 2017 ). Scale bars (D–H) = 20 μm; the side length of the dashed-line square = 5 μm. Data are presented as mean ± SEM. Statistical tests: unpaired two-tailed t -test (K) ; * p

    Article Snippet: Primary antibodies used were as follows: Rabbit anti-HVCN1 (Origene, TA328862, 1:1000), horseradish peroxidase (HRP) conjugated mouse anti-HA (Millipore, H6533, 1:10, 000), mouse anti-β-tubulin (HUABIO, Hangzhou, China, M1305-2, 1:2000), mouse anti-β-actin (Sigma, A5441, 1:10,000).

    Techniques: Expressing, In Vitro, Cell Culture, Derivative Assay, Western Blot, Plasmid Preparation, In Vivo, Immunofluorescence, Mouse Assay, Injection, Labeling, Isolation, Two Tailed Test

    Neutralizing HVCN1 with antibody enhances myelin debris clearance in the brain. (A,B) The binding patterns of the HVCN1 antibody to cells without (upper row) or with Triton X-100 permeabilization (lower row). Confocal images of GFP (green), HVCN1 (red) in 293T cells overexpressed with Plenti-HVCN1-GFP (A) . Confocal images of CD11b (green), HVCN1 (red) in BMDM cells (B) . (C) Schematic in vivo experiment design: CFSE labeled myelin was co-injected with IgG on one side or with an HVCN1 antibody on the other side of the S1 cerebral cortex of the mouse. (D–F) Representative images of the residual myelin (green) taken in every 36 or 48 μm thickness of brain section (D) and quantification of its volume (E) and its fluorescence intensity (F) ( n = 9). (G) Confocal images of the Iba1 + microglia (red), HVCN1 (gray), and phagocytized myelin (green). Scale bars = 100 μm (D) or 20 μm (A,B,G) , and the side length of the dashed-line square = 5 μm (A,B,G) . Data are presented as mean ± SEM. Statistical tests: paired two-tailed t -test (E,F) ; * p

    Journal: Frontiers in Cellular Neuroscience

    Article Title: Neutralization of Hv1/HVCN1 With Antibody Enhances Microglia/Macrophages Myelin Clearance by Promoting Their Migration in the Brain

    doi: 10.3389/fncel.2021.768059

    Figure Lengend Snippet: Neutralizing HVCN1 with antibody enhances myelin debris clearance in the brain. (A,B) The binding patterns of the HVCN1 antibody to cells without (upper row) or with Triton X-100 permeabilization (lower row). Confocal images of GFP (green), HVCN1 (red) in 293T cells overexpressed with Plenti-HVCN1-GFP (A) . Confocal images of CD11b (green), HVCN1 (red) in BMDM cells (B) . (C) Schematic in vivo experiment design: CFSE labeled myelin was co-injected with IgG on one side or with an HVCN1 antibody on the other side of the S1 cerebral cortex of the mouse. (D–F) Representative images of the residual myelin (green) taken in every 36 or 48 μm thickness of brain section (D) and quantification of its volume (E) and its fluorescence intensity (F) ( n = 9). (G) Confocal images of the Iba1 + microglia (red), HVCN1 (gray), and phagocytized myelin (green). Scale bars = 100 μm (D) or 20 μm (A,B,G) , and the side length of the dashed-line square = 5 μm (A,B,G) . Data are presented as mean ± SEM. Statistical tests: paired two-tailed t -test (E,F) ; * p

    Article Snippet: Primary antibodies used were as follows: Rabbit anti-HVCN1 (Origene, TA328862, 1:1000), horseradish peroxidase (HRP) conjugated mouse anti-HA (Millipore, H6533, 1:10, 000), mouse anti-β-tubulin (HUABIO, Hangzhou, China, M1305-2, 1:2000), mouse anti-β-actin (Sigma, A5441, 1:10,000).

    Techniques: Binding Assay, In Vivo, Labeling, Injection, Fluorescence, Two Tailed Test

    HVCN1 deletion impairs lysosome acidification during myelin phagocytosis in vitro . (A) Representative images show that HVCN1 (red) is colocalized with lysosome marker TMEM192 (green) in 293T cells overexpressed Plenti-HVCN1-mCherry and TMEM192-GFP plasmid. Scale bar = 50 μm (upper row) or 10 μm (lower row). Flow cytometry chart (B) and the quantification graphs (C,D) show that HVCN1 knockout decreases both the proportion of cells phagocytizing myelin (C) and the relative phagocytic index (D) in pHrodo-myelin phagocytosis assay in 293T cells ( n = 3). Flow cytometry chart (E) and the quantification graphs (F,G) show that overexpression of HVCN1 does not affect the proportion of phagocytic cells (F) and the relative phagocytic index (G) in pHrodo-myelin phagocytosis assay in 293T cell ( n = 3). Data are presented as mean ± SEM. Statistical tests: unpaired two-tailed t -test (C,D,F,G) ; * p

    Journal: Frontiers in Cellular Neuroscience

    Article Title: Neutralization of Hv1/HVCN1 With Antibody Enhances Microglia/Macrophages Myelin Clearance by Promoting Their Migration in the Brain

    doi: 10.3389/fncel.2021.768059

    Figure Lengend Snippet: HVCN1 deletion impairs lysosome acidification during myelin phagocytosis in vitro . (A) Representative images show that HVCN1 (red) is colocalized with lysosome marker TMEM192 (green) in 293T cells overexpressed Plenti-HVCN1-mCherry and TMEM192-GFP plasmid. Scale bar = 50 μm (upper row) or 10 μm (lower row). Flow cytometry chart (B) and the quantification graphs (C,D) show that HVCN1 knockout decreases both the proportion of cells phagocytizing myelin (C) and the relative phagocytic index (D) in pHrodo-myelin phagocytosis assay in 293T cells ( n = 3). Flow cytometry chart (E) and the quantification graphs (F,G) show that overexpression of HVCN1 does not affect the proportion of phagocytic cells (F) and the relative phagocytic index (G) in pHrodo-myelin phagocytosis assay in 293T cell ( n = 3). Data are presented as mean ± SEM. Statistical tests: unpaired two-tailed t -test (C,D,F,G) ; * p

    Article Snippet: Primary antibodies used were as follows: Rabbit anti-HVCN1 (Origene, TA328862, 1:1000), horseradish peroxidase (HRP) conjugated mouse anti-HA (Millipore, H6533, 1:10, 000), mouse anti-β-tubulin (HUABIO, Hangzhou, China, M1305-2, 1:2000), mouse anti-β-actin (Sigma, A5441, 1:10,000).

    Techniques: In Vitro, Marker, Plasmid Preparation, Flow Cytometry, Knock-Out, Phagocytosis Assay, Over Expression, Two Tailed Test

    AAT augmentation therapy increases HVCN1 neutrophil plasma membrane expression. HVCN1 membrane expression of AATD neutrophils before (day 0) and 2 days after augmentation therapy (day 2) assessed by flow cytometry. HVCN1 expressing neutrophils were significantly higher on day 2 after therapy ( p = 0.014, n = 3, Student’s paired t test).

    Journal: Medicina

    Article Title: Alpha-1 Antitrypsin Augmentation Inhibits Proteolysis of Neutrophil Membrane Voltage-Gated Proton Channel-1 in Alpha-1 Deficient Individuals

    doi: 10.3390/medicina57080814

    Figure Lengend Snippet: AAT augmentation therapy increases HVCN1 neutrophil plasma membrane expression. HVCN1 membrane expression of AATD neutrophils before (day 0) and 2 days after augmentation therapy (day 2) assessed by flow cytometry. HVCN1 expressing neutrophils were significantly higher on day 2 after therapy ( p = 0.014, n = 3, Student’s paired t test).

    Article Snippet: For immunological detection of HVCN1 1 μg/mL rabbit anti-HVCN1 antibody (Sigma, SAB3500536) followed by HRP-linked goat anti-rabbit IgG secondary antibody was employed.

    Techniques: Expressing, Flow Cytometry

    HVCN1 is reduced on activated neutrophil plasma membranes by serine proteases. ( a ) Time course of TNF-α/fMLP (10 ng/10 μM) neutrophil activation with HVCN1 membrane expression assessed by flow cytometry. Significantly increased abundance of HVCN1 at 10 min compared to 0 min ( p = 0.001, n = 6, one-way ANOVA, post hoc Tukeys’ test). ( b ) TNF-α/fMLP activation of neutrophils for 30 min (Con) in the presence of nonspecific protease inhibitors EDTA, E64 or pefabloc (Pef). Pef treatment resulted in significantly increased abundance of HVCN1 ( p

    Journal: Medicina

    Article Title: Alpha-1 Antitrypsin Augmentation Inhibits Proteolysis of Neutrophil Membrane Voltage-Gated Proton Channel-1 in Alpha-1 Deficient Individuals

    doi: 10.3390/medicina57080814

    Figure Lengend Snippet: HVCN1 is reduced on activated neutrophil plasma membranes by serine proteases. ( a ) Time course of TNF-α/fMLP (10 ng/10 μM) neutrophil activation with HVCN1 membrane expression assessed by flow cytometry. Significantly increased abundance of HVCN1 at 10 min compared to 0 min ( p = 0.001, n = 6, one-way ANOVA, post hoc Tukeys’ test). ( b ) TNF-α/fMLP activation of neutrophils for 30 min (Con) in the presence of nonspecific protease inhibitors EDTA, E64 or pefabloc (Pef). Pef treatment resulted in significantly increased abundance of HVCN1 ( p

    Article Snippet: For immunological detection of HVCN1 1 μg/mL rabbit anti-HVCN1 antibody (Sigma, SAB3500536) followed by HRP-linked goat anti-rabbit IgG secondary antibody was employed.

    Techniques: Activation Assay, Expressing, Flow Cytometry

    Reduced voltage-gated hydrogen channel 1 (HVCN1) in neutrophils of individuals with alpha-1 antitrypsin deficiency (AATD). ( a ) Representative flow cytometry data histogram showing abundance of cell surface HVCN1 in healthy control (HC) (blue) and AATD (green) neutrophils compared to the isotype control (purple). ( b ) Neutrophil membrane levels of HVCN1 quantified by flow cytometry were expressed as mean fluorescence intensity (MFI). Graph illustrates a significantly lower abundance of HVCN1 in AATD neutrophils ( n = 9 subjects per group, p = 0.04, Student’s t test). ( c ) Representative Western blot depicting HVCN1 expression in neutrophil whole cell lysates. β-actin was used as a loading control. ( d ) Graph depicting densitometry units (DU) for HVCN1 immunobands, showing significantly decreased protein level of HVCN1 in neutrophil whole cell lysates of individuals with AATD compared to HC ( n = 7 subjects per group, p = 0.02, Student’s t test).

    Journal: Medicina

    Article Title: Alpha-1 Antitrypsin Augmentation Inhibits Proteolysis of Neutrophil Membrane Voltage-Gated Proton Channel-1 in Alpha-1 Deficient Individuals

    doi: 10.3390/medicina57080814

    Figure Lengend Snippet: Reduced voltage-gated hydrogen channel 1 (HVCN1) in neutrophils of individuals with alpha-1 antitrypsin deficiency (AATD). ( a ) Representative flow cytometry data histogram showing abundance of cell surface HVCN1 in healthy control (HC) (blue) and AATD (green) neutrophils compared to the isotype control (purple). ( b ) Neutrophil membrane levels of HVCN1 quantified by flow cytometry were expressed as mean fluorescence intensity (MFI). Graph illustrates a significantly lower abundance of HVCN1 in AATD neutrophils ( n = 9 subjects per group, p = 0.04, Student’s t test). ( c ) Representative Western blot depicting HVCN1 expression in neutrophil whole cell lysates. β-actin was used as a loading control. ( d ) Graph depicting densitometry units (DU) for HVCN1 immunobands, showing significantly decreased protein level of HVCN1 in neutrophil whole cell lysates of individuals with AATD compared to HC ( n = 7 subjects per group, p = 0.02, Student’s t test).

    Article Snippet: For immunological detection of HVCN1 1 μg/mL rabbit anti-HVCN1 antibody (Sigma, SAB3500536) followed by HRP-linked goat anti-rabbit IgG secondary antibody was employed.

    Techniques: Flow Cytometry, Fluorescence, Western Blot, Expressing

    NE activity on AATD neutrophil membranes cleaves HVCN1. ( a ) Significantly increased NE activity on healthy control (HC) neutrophil plasma membranes after TNF-α (10 ng)/fMLP (10 μM) stimulation ( n = 5 biological repeats, as measured by FRET assay ( p = 0.01, one-way ANOVA, post hoc Bonferroni test)). ( b ) Activity of NE on unstimulated HC or AATD neutrophil plasma membranes. AATD neutrophils exhibit significantly increased activity of NE compared to HC ( n = 3 subjects per group, p = 0.03, Student’s t test). ( c ) HC neutrophils (2 × 10 6 ) were untreated (Con) or exposed to NE (20 nM) over a 60 min time course. Exposure to NE significantly reduced membrane expression of HVCN1 after 60 min ( p = 0.0004, n = 5, one-way ANOVA, post hoc Dunnetts’ test).

    Journal: Medicina

    Article Title: Alpha-1 Antitrypsin Augmentation Inhibits Proteolysis of Neutrophil Membrane Voltage-Gated Proton Channel-1 in Alpha-1 Deficient Individuals

    doi: 10.3390/medicina57080814

    Figure Lengend Snippet: NE activity on AATD neutrophil membranes cleaves HVCN1. ( a ) Significantly increased NE activity on healthy control (HC) neutrophil plasma membranes after TNF-α (10 ng)/fMLP (10 μM) stimulation ( n = 5 biological repeats, as measured by FRET assay ( p = 0.01, one-way ANOVA, post hoc Bonferroni test)). ( b ) Activity of NE on unstimulated HC or AATD neutrophil plasma membranes. AATD neutrophils exhibit significantly increased activity of NE compared to HC ( n = 3 subjects per group, p = 0.03, Student’s t test). ( c ) HC neutrophils (2 × 10 6 ) were untreated (Con) or exposed to NE (20 nM) over a 60 min time course. Exposure to NE significantly reduced membrane expression of HVCN1 after 60 min ( p = 0.0004, n = 5, one-way ANOVA, post hoc Dunnetts’ test).

    Article Snippet: For immunological detection of HVCN1 1 μg/mL rabbit anti-HVCN1 antibody (Sigma, SAB3500536) followed by HRP-linked goat anti-rabbit IgG secondary antibody was employed.

    Techniques: Activity Assay, Expressing